Detalhe da pesquisa
1.
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming.
Cancer Cell Int
; 24(1): 37, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238756
2.
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9.
Cancer Sci
; 114(3): 822-836, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369902
3.
LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.
Cancer Sci
; 114(3): 870-884, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382614
4.
Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.
Mol Ther
; 30(3): 1018-1035, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793975
5.
The function of prohibitins in mitochondria and the clinical potentials.
Cancer Cell Int
; 22(1): 343, 2022 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348375
6.
The cancer metabolic reprogramming and immune response.
Mol Cancer
; 20(1): 28, 2021 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33546704
7.
Induction of Pro-Inflammatory Response via Activated Macrophage-Mediated NF-κB and STAT3 Pathways in Gastric Cancer Cells.
Cell Physiol Biochem
; 47(4): 1399-1410, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29929193
8.
Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination.
Int J Biol Sci
; 20(4): 1125-1141, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385081
9.
Cellular metabolism: A key player in cancer ferroptosis.
Cancer Commun (Lond)
; 44(2): 185-204, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38217522
10.
Ferritinophagy: research advance and clinical significance in cancers.
Cell Death Discov
; 9(1): 463, 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110359
11.
Clinical significance and integrative analysis of the cuproptosis-associated genes in head and neck squamous cell carcinoma.
Aging (Albany NY)
; 15(6): 1964-1976, 2023 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947706
12.
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential.
Exp Mol Med
; 55(7): 1357-1370, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394582
13.
Organoids: opportunities and challenges of cancer therapy.
Front Cell Dev Biol
; 11: 1232528, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37576596
14.
The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials.
Front Oncol
; 13: 1100134, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36756159
15.
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
J Exp Clin Cancer Res
; 42(1): 59, 2023 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36899389
16.
The roles of long non-coding RNAs in lung cancer.
J Cancer
; 13(1): 174-183, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34976181
17.
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.
Oncogene
; 41(7): 1024-1039, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997215
18.
Phase separation in Cancer: From the Impacts and Mechanisms to Treatment potentials.
Int J Biol Sci
; 18(13): 5103-5122, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35982902
19.
Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting desmocollin-2.
Mol Ther Oncolytics
; 24: 612-623, 2022 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35284624
20.
Rac1, A Potential Target for Tumor Therapy.
Front Oncol
; 11: 674426, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079763